WUC for sale, page-17

Lots of hope; not much change. Searching for a new director, investigating a new exchange listing, assessing ways to maximize ablation economics, figuring out how to monetize vanadium. Not a single material announcement here.

Shareholders would do well to read the Q2 financials and MD&A. $415k cash on hand at 6/30/17 and a cash burn rate of $150k-$180k per month. Accounts payable and accrued liabilities of $652K. No cash infusion since the March 31 private placement. No asset impairment charge in spite of the Boyer lease forfeiture, the STB option expiration, and the CDPHE ablation regulation determination.